Ignite Creation Date:
2024-05-06 @ 8:34 AM
Last Modification Date:
2024-10-26 @ 12:01 PM
Study NCT ID:
NCT02763566
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-16
First Post:
2016-05-04
Brief Title:
A Study of Abemaciclib LY2835219 in Participants With Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2016-05-04
First Submit QC Date:
May 4 2016
Study First Post Date:
2016-05-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-03-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-14
Last Update Post Date:
2024-04-16
Last Update Post Date Type:
ACTUAL